EJVES Vascular Forum, published by Elsevier, is a premier open access journal focusing on the interdisciplinary field of vascular surgery and cardiovascular medicine. Since its inception in 2001, the journal has provided a vital platform for the dissemination of high-quality research and innovative clinical practices, addressing critical issues in vascular health. With an ISSN of 2666-688X, it has gained recognition within its community, attaining a Q3 quartile ranking in both cardiology and surgery categories as of 2023, and showcasing its relevance and impact within the medical research landscape. Situated in the United Kingdom and accessible globally, the EJVES Vascular Forum invites contributions that foster collaboration and enhance knowledge in vascular surgery, making it an essential resource for researchers, professionals, and students alike. The journal's ranking within Scopus highlights its position among peers, adding further credence to its objectives of advancing science and improving patient care in the cardiovascular realm. By publishing rigorously peer-reviewed articles, the journal aims to be the go-to source of information and innovation for those dedicated to the progress of vascular health.

ACTA OTO-LARYNGOLOGICA is a prestigious academic journal focusing on the field of otorhinolaryngology, published by Taylor & Francis Ltd in the United Kingdom. With an ISSN of 0001-6489 and E-ISSN 1651-2251, this journal has been a cornerstone in the dissemination of research in otolaryngology since its inception in 1918. It maintains a solid impact factor in the scholarly community, categorized in 2023 as Q3 in Medicine (miscellaneous) and Q2 specifically in Otorhinolaryngology, indicating its significance and quality of published work. Researchers and practitioners benefit from comprehensive articles that offer insights and advancements in clinical practices, surgical techniques, and emerging trends in the field. Though it follows a subscription model, ACTA OTO-LARYNGOLOGICA strives to remain accessible for professionals seeking the latest research findings that can enhance patient care and clinical decision-making. By fostering a platform for quality scholarship, the journal plays an essential role in advancing the science and practice of otorhinolaryngology, making it invaluable for researchers, medical professionals, and students alike.

Egyptian Journal of Otolaryngology (EJOT) is a premier open access journal dedicated to advancing the field of otorhinolaryngology. Published by Springer, the journal has been an essential resource for researchers and practitioners since its transition to open access in 2012. With an ISSN of 1012-5574 and E-ISSN 2090-8539, EJOT aims to facilitate the dissemination of high-quality research, covering a broad spectrum of topics within otolaryngology. The journal's significance is underscored by its current ranking in the Q3 category of the Scopus Otorhinolaryngology category, and it is positioned in the 23rd percentile of its field, reflecting its commitment to scholarly excellence. Researchers, professionals, and students alike will find valuable insights and innovative studies in the journal's articles, contributing to ongoing education and the advancement of best practices in ear, nose, and throat medicine. The journal is based in Germany with its operations centered at ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY 10004, UNITED STATES, ensuring a global reach in the academic community.

Laryngoscope Investigative Otolaryngology is a prominent open access journal published by Wiley, dedicated to advancing research and knowledge within the field of otolaryngology and surgical practices. Since its inception in 2016, this journal has undergone a transformative phase and has quickly established itself in the academic community, achieving Q2 quartile rankings in both Otorhinolaryngology and Surgery for the year 2023. With an ISSN of 2378-8038, it serves as a vital repository of innovative research, insights, and reviews, catering primarily to researchers, medical professionals, and students. The journal emphasizes accessibility, allowing wide dissemination of pivotal findings essential for fostering collaboration and enhancing clinical practices. Through its rigorous peer-review process and commitment to quality, Laryngoscope Investigative Otolaryngology seeks to contribute significantly to the ongoing dialogue and improvements within the health care landscape.

The International Forum of Allergy & Rhinology, published by Wiley, is a leading journal dedicated to advancing the field of allergy, rhinology, and related health issues. With an ISSN of 2042-6976 and an E-ISSN of 2042-6984, this esteemed journal showcases high-quality research and innovative findings by publishing original articles, reviews, and clinical case studies. As of 2023, it holds impressive rankings within the Scopus metrics, placing it in the top 2% for Medicine in Otorhinolaryngology and in the top 16% for Immunology and Allergy, highlighting its influence and credibility in these specialized fields. Operating without an open access model, the journal aims to offer comprehensive insights into the diagnosis and treatment of allergic conditions and their impact on rhinology, fostering a deeper understanding among researchers and practitioners. Located in Hoboken, NJ, the journal has been at the forefront of scientific exploration since its inception in 2011, continuing to play a pivotal role in informing the academic community and influencing clinical practice up to 2024 and beyond.

Gastroenterology, published by W B Saunders Co-Elsevier Inc, is a premier journal dedicated to advancing the knowledge and practice within the fields of gastroenterology and hepatology. Established in 1945 and covering a wide range of topics related to digestive health, this journal holds a distinguished position in the academic community, as evidenced by its impressive Q1 status in both Gastroenterology and Hepatology categories, and its high rankings (4th in both disciplines) in Scopus, placing it in the top percentile for scholarly impact. With its commitment to publishing high-quality research, reviews, and clinical studies, Gastroenterology provides an essential resource for researchers, healthcare professionals, and students seeking cutting-edge insights that inform clinical practices and enhance patient care. Although it does not currently offer open access, the journal continues to serve as a vital platform for disseminating meaningful research that shapes the future of digestive disease management.

Metabolic Syndrome and Related Disorders is an esteemed journal published by MARY ANN LIEBERT, INC, focusing on the multifaceted aspects of metabolic syndrome, including its interaction with chronic diseases such as diabetes, cardiovascular conditions, and obesity. Since its inception in 2003, this journal has established itself as a vital resource for researchers, healthcare professionals, and students dedicated to advancing knowledge in the fields of endocrinology, internal medicine, and metabolic disorders. With an impact factor reflective of its academic significance, Metabolic Syndrome and Related Disorders is recognized within the Q2 and Q3 quartiles in its respective categories, solidifying its reputation among scientific and clinical communities. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and reviews that foster innovative solutions and improve patient outcomes. The journal's gradual convergence towards 2024 presents an exciting opportunity for continued exploration and dialogue about metabolic-related health challenges.

Esophagus is a prestigious journal published by SPRINGER JAPAN KK, dedicated to advancing the field of gastroenterology. With an ISSN of 1612-9059 and E-ISSN 1612-9067, this journal has been a significant resource for researchers and practitioners since its inception in 2003. Covering a comprehensive range of topics related to esophageal health, diseases, and treatment advancements, Esophagus has established itself in the academic community, boasting a notable impact factor and achieving a ranking of #60 out of 167 in the gastroenterology category, placing it in the 64th percentile. The journal currently holds a Q2 status for the year 2023, emphasizing its contribution to high-quality research in the field. Located in the heart of Tokyo, Japan, this journal aims to foster collaboration and innovation within the gastroenterological community, welcoming submission of original research articles, review papers, and case studies that can significantly impact patient care and clinical practices.

Movement Disorders Clinical Practice, published by WILEY, is an essential peer-reviewed journal dedicated to advancing the understanding and treatment of movement disorders from a clinical perspective. With an ISSN of 2330-1619, this journal serves as a vital resource for researchers, clinicians, and students engaged in neurology and clinical neuroscience. Since its inception in 2014, the journal has established itself within the medical community, currently positioned in the Q2 category for both Neurology and Neurology (Clinical), reflecting its influence and reputation. Although it does not offer open access, the journal is integral for disseminating high-quality research and clinical insights, thereby contributing significantly to improved patient care and outcomes in the field of movement disorders. Based in Hoboken, NJ, it continues to attract contributions from leading experts and aims to foster a deeper understanding and dialogue surrounding contemporary challenges and advancements in movement disorder treatment.

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.